PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10803320-0	2000	Phase I study of CBT-1 and Taxol in patients with Taxol resistant cancers.	Paclitaxel	50-55	succinate dehydrogenase complex subunit D	Homo sapiens	17-22	
10803320-1	2000	CBT-1, a natural product, was studied as an MDR modulator with Taxol (135 mg/m2) in an escalating dose Phase I clinical trial.	Paclitaxel	63-68	succinate dehydrogenase complex subunit D	Homo sapiens	0-5